Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR Part 1308—Schedules of controlled substances
21 CFR Part 1308—Schedules of controlled substances, “Schedules of controlled substances”, is a CFR part of 21 CFR Chapter II—DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE; it is made under 4 laws; in force.
https://ontology.bommaritollc.com/id/01a0f094-b8cd-732f-a957-b60db5d17f2b
Elsewhere
Facts
| adms:identifier | |
| authority note | 21 U.S.C. 811, 812, 871(b), 956(b), unless otherwise noted.en |
| eli:based_on | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR Part 1308 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Schedules of controlled substancesen |
| schema:url | |
| skos:prefLabel | 21 CFR Part 1308—Schedules of controlled substancesen |
| source note | 38 FR 8254, Mar. 30, 1973, unless otherwise noted. Redesignated at 38 FR 26609, Sept. 24, 1973.en |
Related
Cited by (60)eli:cites
- 21 CFR 1300.01 Definitions relating to controlled substances.
- 21 CFR 1300.02 Definitions relating to listed chemicals.
- 21 CFR 1301.13 Application for registration; time for application; expiration date; registration for independent activities; application forms, fees, contents and signature; coincident activities.
- 21 CFR 1301.35 Certificate of registration; denial of registration.
- 21 CFR 1303.15 Procurement quotas.
- 21 CFR 1303.22 Procedure for applying for individual manufacturing quotas.
- 21 CFR 1312.12 Application for import permit; return information.
- 21 CFR 1312.18 Import declaration.
- 21 CFR 1312.22 Application for export or reexport permit; return information.
- 21 CFR 1312.27 Export/reexport declaration.
- 21 CFR 312.58 Inspection of sponsor's records and reports.
- 25 CFR 11.452 Possession of a controlled substance.
- 31 CFR 605.1 Conduct on Bureau of Engraving and Printing property.
- 32 CFR 273.3 Definitions.
- 33 CFR 95.010 Definition of terms as used in this part.
- 38 CFR 1.515 Disclosure of information to participate in state prescription drug monitoring programs.
- 40 CFR 266.506 Conditional exemption for hazardous waste pharmaceuticals that are also controlled substances and household waste pharmaceuticals collected by an authorized collector.
- 41 CFR 102-40.30 What definitions apply to this part?
- 49 CFR 219.5 Definitions.
- 49 CFR 350.207 MCSAP administration: Conditions to qualify for funds.
- 49 CFR 382.213 Controlled substance use.
- 49 CFR 383.5 Definitions.
- 49 CFR 391.41 Physical qualifications for drivers.
- 49 U.S.C. 31102 Motor carrier safety assistance program
- 7 CFR 1955.105 Real property affected (CONACT).
- 7 CFR 1962.30 Subordination and waiver of liens on chattel security.
- 7 CFR 1962.34 Transfer of chattel security and EO property and assumption of debts.
- 7 CFR 718.2 Definitions.
- 7 CFR 772.6 Subordination of security.
- FR Doc. 2023-06893: Schedules of Controlled Substances: Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
30 more
- FR Doc. 2023-07576: Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I
- FR Doc. 2023-07578: Definition of “Cannabimimetic Agents” and Assignment of an Administration Controlled Substances Code Number for All “Cannabimimetic Agents”
- FR Doc. 2023-20439: Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I
- FR Doc. 2023-23379: Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
- FR Doc. 2023-27289: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I
- FR Doc. 2024-07473: Announcement of Hearing: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) inSchedule I
- FR Doc. 2024-07694: Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I
- FR Doc. 2024-11137: Schedules of Controlled Substances: Rescheduling of Marijuana
- FR Doc. 2024-12504: Announcement of Stayed Hearing: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I
- FR Doc. 2024-21058: Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
- FR Doc. 2024-30359: Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I
- FR Doc. 2024-30798: Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I
- FR Doc. 2025-09988: Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
- FR Doc. 2025-10372: Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I
- FR Doc. 2025-10503: Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I
- FR Doc. 2025-11462: Schedules of Controlled Substances: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I
- FR Doc. 2025-14022: Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
- FR Doc. 2025-19348: Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
- FR Doc. 2025-22495: Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
- FR Doc. 2025-22763: Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
- FR Doc. 2025-22963: Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
- FR Doc. 2026-00954: Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
- FR Doc. 2026-10379: Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
- FR Doc. 2026-10380: Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
- FR Doc. 2026-13364: Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- FR Doc. 2026-13580: Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
- FR Doc. 2026-13581: Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
- FR Doc. 2026-13821: Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
- FR Doc. 2026-16375: Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
- FR Doc. 2026-19400: Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I
Its changes, from (48)eli:changes
- FR Doc. 2023-04364: Schedules of Controlled Substances: Placement of Brorphine in Schedule I
- FR Doc. 2023-07335: Specific Listing for Eutylone, a Currently Controlled Schedule I Substance
- FR Doc. 2023-15249: Schedules of Controlled Substances: Placement of Brorphine in Schedule I; Correction
- FR Doc. 2023-15747: Implementation of the Designer Anabolic Steroid Control Act of 2014
- FR Doc. 2023-15748: Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I
- FR Doc. 2023-17778: Schedules of Controlled Substances: Placement of Metonitazene in Schedule I
- FR Doc. 2023-23982: Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV
- FR Doc. 2023-26694: Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I
- FR Doc. 2023-27243: Schedules of Controlled Substances: Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA into Schedule I
- FR Doc. 2023-27292: Specific Listing for Three Currently Controlled Schedule I Substances
- FR Doc. 2024-05543: Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I
- FR Doc. 2024-07684: Schedules of Controlled Substances: Placement of Etodesnitazene, N-Pyrrolidino Etonitazene, and Protonitazene in Schedule I
- FR Doc. 2024-07689: Schedules of Controlled Substances: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I of the Controlled Substances Act
- FR Doc. 2024-16391: Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
- FR Doc. 2024-18087: Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV
- FR Doc. 2024-24083: Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I
- FR Doc. 2024-24635: Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I
- FR Doc. 2024-31130: Schedules of Controlled Substances: Extension of Temporary Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act
- FR Doc. 2025-09989: Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction
- FR Doc. 2025-14037: Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
- FR Doc. 2025-15177: Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance
- FR Doc. 2025-15566: Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
- FR Doc. 2025-18103: Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I
- FR Doc. 2025-19542: Schedules of Controlled Substances: Temporary Placement of Ethyleneoxynitazene, Methylenedioxynitazene, 5-Methyl Etodesnitazene, N-Desethyl Etonitazene, N-Desethyl Protonitazene, N,N-Dimethylamino Etonitazene, and N-Pyrrolidino Isotonitazene in Schedule I
- FR Doc. 2025-20004: Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I
- FR Doc. 2025-22496: Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I of the Controlled Substances Act
- FR Doc. 2025-22540: Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I of the Controlled Substances Act
- FR Doc. 2025-22960: Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act
- FR Doc. 2025-23717: Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
- FR Doc. 2026-00362: Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
18 more
- FR Doc. 2026-00633: Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
- FR Doc. 2026-00907: Definition of “Cannabimimetic Agents” and Assignment of an Administration Controlled Substances Code Number for All “Cannabimimetic Agents”
- FR Doc. 2026-04112: Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
- FR Doc. 2026-05064: Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
- FR Doc. 2026-05618: Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
- FR Doc. 2026-08104: Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
- FR Doc. 2026-08176: Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
- FR Doc. 2026-08517: Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
- FR Doc. 2026-08595: Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
- FR Doc. 2026-09566: Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
- FR Doc. 2026-10253: Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
- FR Doc. 2026-12653: Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
- FR Doc. 2026-12654: Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
- FR Doc. 2026-16413: Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
- FR Doc. 2026-17429: Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
- FR Doc. 2026-17531: Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- FR Doc. 2026-17536: Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
- FR Doc. 2026-19231: Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
Parts (9)schema:isPartOf
- 21 CFR Part 1308, Subject Group: Excluded Nonnarcotic Substances—Excluded Nonnarcotic Substances
- 21 CFR Part 1308, Subject Group: Excluded Veterinary Anabolic Steroid Implant Products—Excluded Veterinary Anabolic Steroid Implant Products
- 21 CFR Part 1308, Subject Group: Exempt Anabolic Steroid Products—Exempt Anabolic Steroid Products
- 21 CFR Part 1308, Subject Group: Exempt Cannabis Plant Material, and Products Made Therefrom, that Contain Tetrahydrocannabinols—Exempt Cannabis Plant Material, and Products Made Therefrom, that Contain Tetrahydrocannabinols
- 21 CFR Part 1308, Subject Group: Exempt Chemical Preparations—Exempt Chemical Preparations
- 21 CFR Part 1308, Subject Group: Exempted Prescription Products—Exempted Prescription Products
- 21 CFR Part 1308, Subject Group: General Information—General Information
- 21 CFR Part 1308, Subject Group: Hearings—Hearings
- 21 CFR Part 1308, Subject Group: Schedules—Schedules